Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The Medicaid program now in Pennsylvania only covers GLP-1 drugs for people with diabetes or those who meet a narrower set of criteria, such as those with sleep apnea and a body mass index of at least 35
If you're a small business employee whose boss uses ICHRA (Individual Coverage Health Reimbursement Arrangement) to supply health benefits, that comes with a bit of good news
A 2026 Journal of the American Academy of Dermatology cohort study specifically examined new-onset hair loss with semaglutide and tirzepatide, showing that this is now an active area of dermatology research
You are eating less food overall
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide or tirzepatide
There was no difference in the risk of CV death when GLP-1RA were compared with SGLT-2 inhibitors
US$ 29.75
US$ 29.74
US$ 26.04
US$ 20.90
US$ 21.17
US$ 27.63
